Fax: (901) 521-9005
Original Article
You have free access to this content
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia
Article first published online: 2 NOV 2009
DOI: 10.1002/cncr.24712
Copyright © 2010 American Cancer Society
Additional Information
How to Cite
Inaba, H., Stewart, C. F., Crews, K. R., Yang, S., Pounds, S., Pui, C.-H., Rubnitz, J. E., Razzouk, B. I. and Ribeiro, R. C. (2010), Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia. Cancer, 116: 98–105. doi: 10.1002/cncr.24712
Publication History
- Issue published online: 11 JAN 2010
- Article first published online: 2 NOV 2009
- Manuscript Accepted: 21 APR 2009
- Manuscript Received: 31 MAR 2009
Funded by
- Cancer Center Core Grant. Grant Number: CA 21765
- National Cancer Institute and by the American Lebanese Syrian Associated Charities
- Abstract
- Article
- References
- Cited By

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)